中商官网
研究报告
苑东生物（688513）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 162000000.0000 | 11021000.0000 | 15792000.0000 | 14731300.0000 | 255000000.0000 | 97418700.0000 | 157000000.0000 |
| 2014 | 209000000.0000 | 28202500.0000 | 34272300.0000 | 29232700.0000 | 283000000.0000 | 95759200.0000 | 187000000.0000 |
| 2015 | 241000000.0000 | 41619100.0000 | 43916500.0000 | 37619200.0000 | 312000000.0000 | 67293300.0000 | 244000000.0000 |
| 2016 | 339000000.0000 | 39416800.0000 | 65511200.0000 | 57316600.0000 | 520000000.0000 | 130000000.0000 | 390000000.0000 |
| 2017 | 476000000.0000 | 74267900.0000 | 74470300.0000 | 64365600.0000 | 592000000.0000 | 147000000.0000 | 445000000.0000 |
| 2018 | 769000000.0000 | 149000000.0000 | 148000000.0000 | 135000000.0000 | 790000000.0000 | 208000000.0000 | 582000000.0000 |
| 2019 | 947000000.0000 | 115000000.0000 | 116000000.0000 | 109000000.0000 | 987000000.0000 | 290000000.0000 | 697000000.0000 |
| 2020 | 922000000.0000 | 199000000.0000 | 199000000.0000 | 178000000.0000 | 2531000000.0000 | 436000000.0000 | 2095000000.0000 |
| 2021 | 1023000000.0000 | 244000000.0000 | 247000000.0000 | 232000000.0000 | 2775000000.0000 | 484000000.0000 | 2292000000.0000 |
| 2022 | 1171000000.0000 | 261000000.0000 | 262000000.0000 | 247000000.0000 | 3018000000.0000 | 573000000.0000 | 2444000000.0000 |
| 2023 | 1117000000.0000 | 242000000.0000 | 242000000.0000 | 227000000.0000 | 3347000000.0000 | 743000000.0000 | 2603000000.0000 |
| 2024 | 1350000000.0000 | 252000000.0000 | 253000000.0000 | 238000000.0000 | 3400000000.0000 | 702000000.0000 | 2698000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 5.56 | 9.75 | 6.19 | 9.8300 | 3.2600 | 28.19 | 0.64 |
| 2014 | 13.40 | 16.40 | 12.11 | 16.9600 | 3.6200 | 37.54 | 0.74 |
| 2015 | 17.01 | 18.22 | 14.08 | -- | 3.5400 | 54.96 | 0.77 |
| 2016 | 11.50 | 19.32 | 12.60 | 20.3700 | 1.8800 | -- | 0.65 |
| 2017 | 8.82 | 15.65 | 12.58 | 15.7800 | 1.4600 | 9.19 | 0.80 |
| 2018 | 11.44 | 19.25 | 18.73 | 26.3500 | 1.6400 | 10.80 | 0.97 |
| 2019 | 6.02 | 12.25 | 11.75 | 17.5400 | 1.6500 | 9.04 | 0.96 |
| 2020 | 13.23 | 21.58 | 7.86 | 14.9400 | 1.4500 | 7.67 | 0.36 |
| 2021 | 13.59 | 24.14 | 8.90 | 10.6300 | 1.5300 | 8.75 | 0.37 |
| 2022 | 14.35 | 22.37 | 8.68 | 10.4800 | 1.6000 | 9.39 | 0.39 |
| 2023 | 14.59 | 21.67 | 7.23 | 9.0000 | 1.4800 | 8.69 | 0.33 |
| 2024 | 13.26 | 18.74 | 7.44 | 9.1400 | 1.9300 | 9.07 | 0.40 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 38.20 | 61.57 | 1.0300 | 0.5600 |
| 2014 | 33.84 | 66.08 | 1.1800 | 0.7300 |
| 2015 | 21.57 | 78.21 | 2.7300 | 1.9000 |
| 2016 | 25.00 | 75.00 | 2.8900 | 2.4700 |
| 2017 | 24.83 | 75.17 | 3.1300 | 2.5100 |
| 2018 | 26.33 | 73.67 | 2.7400 | 2.4300 |
| 2019 | 29.38 | 70.62 | 2.2800 | 2.0000 |
| 2020 | 17.23 | 82.77 | 4.9200 | 4.6100 |
| 2021 | 17.44 | 82.59 | 4.1100 | 3.7700 |
| 2022 | 18.99 | 80.98 | 3.2300 | 2.8900 |
| 2023 | 22.20 | 77.77 | 2.8500 | 2.5700 |
| 2024 | 20.65 | 79.35 | 3.2300 | 2.8700 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 153000000.0000 | 17458200.0000 | 36481400.0000 | 3100400.0000 |
| 2014 | 181000000.0000 | 28652300.0000 | 43764100.0000 | 2522500.0000 |
| 2015 | 200000000.0000 | 33475300.0000 | 55632400.0000 | 497200.0000 |
| 2016 | 300000000.0000 | 145000000.0000 | 31785200.0000 | -50100.0000 |
| 2017 | 434000000.0000 | 224000000.0000 | 51652100.0000 | 91500.0000 |
| 2018 | 681000000.0000 | 412000000.0000 | 43633500.0000 | -33200.0000 |
| 2019 | 890000000.0000 | 535000000.0000 | 87482700.0000 | -12800.0000 |
| 2020 | 800000000.0000 | 472000000.0000 | 54104700.0000 | 749100.0000 |
| 2021 | 884000000.0000 | 468000000.0000 | 59958800.0000 | 369300.0000 |
| 2022 | 1003000000.0000 | 474000000.0000 | 90301400.0000 | 2407800.0000 |
| 2023 | 954000000.0000 | 385000000.0000 | 98866800.0000 | 3515000.0000 |
| 2024 | 1171000000.0000 | 446000000.0000 | 107000000.0000 | 3616100.0000 |